You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A Double Blind Placebo Controlled Randomised Parallell Group Phase IIa Study to Evaluate the Histological Changes Cellularity Clinical Efficacy and Safety of AZD1981 in Patients With Moderate to Severe COPD
- Disease
- chronic obstructive pulmonary disease, asthma
- Drug Name
- AZD1981
- Generic Name
- AZD1981
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- May 26, 2008
- Study Name
- D9831C00001
- Study Id
- D9831C00001
- ClinicalTrials.gov ID
- NCT00690482
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
